Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction.
暂无分享,去创建一个
Robert David | Axel Imhof | Gerhard Steinbeck | Stefan Brunner | G. Steinbeck | R. David | A. Imhof | N. Herbach | Markus P. Vallaster | W. Franz | M. Zaruba | L. Israel | Nadja Herbach | Ruediger Wanke | G. Assmann | H. Theiss | Marc-Michael Zaruba | Hans Diogenes Theiss | Markus Vallaster | Ursula Mehl | Rebekka Fischer | Lisa Krieg | Eva Hirsch | Bruno Huber | Petra Nathan | Lars Israel | Gerald Assmann | Josef Mueller-Hoecker | Wolfgang-Michael Franz | S. Brunner | B. Huber | P. Nathan | R. Fischer | R. Wanke | Lisa Krieg | U. Mehl | J. Mueller‐Hoecker | E. Hirsch
[1] R. Bolli,et al. Stromal Cell–Derived Factor-1&agr; Confers Protection Against Myocardial Ischemia/Reperfusion Injury: Role of the Cardiac Stromal Cell–Derived Factor-1&agr;–CXCR4 Axis , 2007 .
[2] H. Broxmeyer,et al. Cell Surface Peptidase CD26/Dipeptidylpeptidase IV Regulates CXCL12/Stromal Cell-Derived Factor-1α-Mediated Chemotaxis of Human Cord Blood CD34+ Progenitor Cells1 , 2002, The Journal of Immunology.
[3] J. Sodroski,et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.
[4] Eric J Topol,et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy , 2003, The Lancet.
[5] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[6] M. Ratajczak,et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. , 2001, Blood.
[7] R. David,et al. Stem-cell homing and tissue regeneration in ischaemic cardiomyopathy , 2003, The Lancet.
[8] S. Ramin,et al. G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38- human cord blood hematopoietic cells. , 2006, Experimental hematology.
[9] Federica Limana,et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] G. Vanhoof,et al. Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamine. , 1988, Clinical chemistry.
[11] B. Fleischer,et al. Molecular analysis of CD26-mediated signal transduction in T cells. , 2000, Immunology letters.
[12] Yan Huang,et al. Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury , 2004, Circulation.
[13] C. Herling,et al. Immunopathology and Infectious Disease Circulating CD26 Is Negatively Associated with Inflammation in Human and Experimental Arthritis , 2022 .
[14] James W. Smyth,et al. Stromal Cell–Derived Factor-1α Is Cardioprotective After Myocardial Infarction , 2008, Circulation.
[15] T. Betsuyaku,et al. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. , 2004, Blood.
[16] M. Schwaiger,et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. , 2006, JAMA.
[17] G. Vanhoof,et al. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects. , 1993, Journal of acquired immune deficiency syndromes.
[18] D. Link,et al. Cytokines and hematopoietic stem cell mobilization , 2006, Journal of cellular biochemistry.
[19] P. Ruiz,et al. Peripheral CD34+ Progenitor Cells Express CD26 and Contain Increased Dipeptidyl Peptidase IV Activity , 1998, Acta Haematologica.
[20] J. Lévesque,et al. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. , 2003, The Journal of clinical investigation.
[21] E. Bosmans,et al. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. , 2000, European journal of biochemistry.
[22] C. Nienaber,et al. Preservation From Left Ventricular Remodeling by Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Use of Granulocyte-Colony–Stimulating Factor (FIRSTLINE-AMI) , 2005, Circulation.
[23] D. Leduc,et al. Leukocyte Elastase Negatively Regulates Stromal Cell-derived Factor-1 (SDF-1)/CXCR4 Binding and Functions by Amino-terminal Processing of SDF-1 and CXCR4* , 2002, The Journal of Biological Chemistry.
[24] I. Komuro,et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] B. Sykes,et al. Solution structure and basis for functional activity of stromal cell‐derived factor‐1; dissociation of CXCR4 activation from binding and inhibition of HIV‐1 , 1997, The EMBO journal.
[26] D. Link,et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. , 2005, Blood.
[27] H. Broxmeyer,et al. Modulation of Hematopoietic Stem Cell Homing and Engraftment by CD26 , 2004, Science.
[28] S. Grundmann,et al. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival. , 2008, Cardiovascular research.
[29] P. Riley,et al. The Stem Cell Movement , 2008, Circulation research.
[30] S. Verma,et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. , 2006, The Journal of clinical investigation.
[31] S. Schoenberg,et al. Autologous Bone Marrow Stem Cell Mobilization Induced by Granulocyte Colony-Stimulating Factor After Subacute ST-Segment Elevation Myocardial Infarction Undergoing Late Revascularization : Final Results From the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infar , 2006 .
[32] Guang-qian Zhou,et al. SDF-1α/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model , 2008, Brain Research.
[33] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[34] A. Zeiher,et al. ransplantation of Progenitor Cells nd Regeneration Enhancement n Acute Myocardial Infarction , 2004 .
[35] Richard T. Lee,et al. Local Delivery of Protease-Resistant Stromal Cell Derived Factor-1 for Stem Cell Recruitment After Myocardial Infarction , 2007, Circulation.
[36] J. Kastrup,et al. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. , 2008, Journal of the American College of Cardiology.
[37] T. Springer,et al. The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood , 1997, The Journal of experimental medicine.
[38] Bernd Hertenstein,et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.
[39] I. Komuro,et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes , 2005, Nature Medicine.
[40] U. Lendeckel,et al. Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review). , 1999, International journal of molecular medicine.
[41] C. Nienaber,et al. Prevention of Left Ventricular Remodeling With Granulocyte Colony-Stimulating Factor After Acute Myocardial Infarction: Final 1-year Results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE- , 2005, Circulation.
[42] Christie M. Orschell,et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist , 2005, The Journal of experimental medicine.
[43] D. Marguet,et al. Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] E. Lakatta,et al. Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. , 2000, American journal of physiology. Heart and circulatory physiology.
[45] M. Hollenberg,et al. Proteolytic processing of SDF-1α reveals a change in receptor specificity mediating HIV-associated neurodegeneration , 2006, Proceedings of the National Academy of Sciences.
[46] David M. Bodine,et al. Bone marrow cells regenerate infarcted myocardium , 2001, Nature.
[47] I. Hoefer,et al. G-csf Administration after Myocardial Infarction in Mice Attenuates Late Ischemic Cardiomyopathy by Enhanced Arteriogenesis , 2022 .
[48] A. Ganser,et al. Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium , 2005, Circulation.
[49] D. Hess,et al. SDF‐1 (CXCL12) Is Upregulated in the Ischemic Penumbra Following Stroke: Association with Bone Marrow Cell Homing to Injury , 2004, Journal of neuropathology and experimental neurology.
[50] Geoffrey C Gurtner,et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.
[51] I. Weissman,et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.
[52] David A. Williams,et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.